$9.11
▲ $0.02 (+0.2%)
XLO
Xilio Therapeutics Inc. Common Stock
Health Care
Investor Score
59C
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
83
Technical
30
Fundamental
82
Growth
38
Fair Value
56
News
58
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.